| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Silvestro M, Rivera CF, Alebrahim D, Vlahos J, Pratama MY, Lu C, Tang C, Harpel Z, Sleiman Tellaoui R, Zias AL, Maldonado DJ, Byrd D, Attur M, Mignatti P, Ramkhelawon B. The Nonproteolytic Intracellular Domain of Membrane-Type 1 Matrix Metalloproteinase Coordinately Modulates Abdominal Aortic Aneurysm and Atherosclerosis in Mice-Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 42: 1244-1253. PMID 36073351 DOI: 10.1161/ATVBAHA.122.317686 |
0.01 |
|
| 2020 |
Attur M, Lu C, Zhang X, Han T, Alexandre C, Valacca C, Zheng S, Meikle S, Dabovic BB, Tassone E, Yang Q, Kolupaeva V, Yakar S, Abramson S, Mignatti P. Membrane-type 1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-proteolytic Mechanism. Iscience. 23: 101789. PMID 33294797 DOI: 10.1016/j.isci.2020.101789 |
0.01 |
|
| 2020 |
Han T, Mignatti P, Abramson SB, Attur M. Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration. Plos One. 15: e0231501. PMID 32330138 DOI: 10.1371/journal.pone.0231501 |
0.01 |
|
| 2018 |
Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes. Molecular Cancer Therapeutics. PMID 29735645 DOI: 10.1158/1535-7163.MCT-17-0646 |
0.01 |
|
| 2017 |
Harbi S, Park H, Gregory M, Lopez P, Chiriboga L, Mignatti P. Arrested Development: Infantile Hemangioma and the Stem Cell Teratogenic Hypothesis. Lymphatic Research and Biology. PMID 28520518 DOI: 10.1089/lrb.2016.0030 |
0.01 |
|
| 2016 |
Harbi S, Wang R, Gregory M, Hanson N, Kobylarz K, Ryan K, Deng Y, Lopez P, Chiriboga L, Mignatti P. Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell. Scientific Reports. 6: 35811. PMID 27786256 DOI: 10.1038/srep35811 |
0.01 |
|
| 2016 |
Winer A, Janosky M, Harrison B, Zhong J, Moussai D, Siyah P, Schatz-Siemers N, Zeng J, Adams S, Mignatti P. INHIBITION OF BREAST CANCER METASTASIS BY PRESURGICAL TREATMENT WITH AN ORAL MATRIX METALLOPROTEINASE INHIBITOR: A PRECLINICAL PROOF-OF-PRINCIPLE STUDY. Molecular Cancer Therapeutics. PMID 27466357 DOI: 10.1158/1535-7163.MCT-16-0194 |
0.01 |
|
| 2016 |
Greenhouse DG, Murphy A, Mignatti P, Zavadil J, Galloway AC, Balsam LB. Mitral valve prolapse is associated with altered extracellular matrix gene expression patterns. Gene. 586: 56-61. PMID 27063507 DOI: 10.1016/j.gene.2016.04.004 |
0.01 |
|
| 2015 |
Mazzieri R, Pietrogrande G, Gerasi L, Gandelli A, Colombo P, Moi D, Brombin C, Ambrosi A, Danese S, Mignatti P, Blasi F, D'Alessio S. Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1. Cancer Research. 75: 4895-909. PMID 26527290 DOI: 10.1158/0008-5472.CAN-15-0378 |
0.01 |
|
| 2015 |
Valacca C, Tassone E, Mignatti P. TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis. Plos One. 10: e0136797. PMID 26331622 DOI: 10.1371/journal.pone.0136797 |
0.01 |
|
| 2015 |
Valacca C, Tassone E, Mignatti P. TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis. Plos One. 10: e0136797. PMID 26331622 DOI: 10.1371/journal.pone.0136797 |
0.01 |
|
| 2015 |
Attur M, Yang Q, Shimada K, Tachida Y, Nagase H, Mignatti P, Statman L, Palmer G, Kirsch T, Beier F, Abramson SB. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26092928 DOI: 10.1096/fj.15-272427 |
0.01 |
|
| 2015 |
Mazzieri R, Pietrogrande G, Gerasi L, Gandelli A, Colombo P, Moi D, Brombin C, Ambrosi A, Danese S, Mignatti P, Blasi F, D'Alessio S. Urokinase receptor promotes skin tumor formation by preventing epithelial cell activation of Notch1 Cancer Research. 75: 4895-4909. DOI: 10.1158/0008-5472.CAN-15-0378 |
0.01 |
|
| 2014 |
Tassone E, Valacca C, Mignatti P. Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling. Journal of Cellular Physiology. PMID 24986796 DOI: 10.1002/jcp.24717 |
0.01 |
|
| 2013 |
Monti M, Donnini S, Morbidelli L, Giachetti A, Mochly-Rosen D, Mignatti P, Ziche M. PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting. Journal of Molecular and Cellular Cardiology. 63: 107-17. PMID 23880610 DOI: 10.1016/J.Yjmcc.2013.07.006 |
0.01 |
|
| 2012 |
Ferrari G, Terushkin V, Wolff MJ, Zhang X, Valacca C, Poggio P, Pintucci G, Mignatti P. TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α. Molecular Cancer Research : McR. 10: 605-14. PMID 22522454 DOI: 10.1158/1541-7786.MCR-11-0507 |
0.01 |
|
| 2010 |
Sharony R, Yu PJ, Park J, Galloway AC, Mignatti P, Pintucci G. Protein targets of inflammatory serine proteases and cardiovascular disease. Journal of Inflammation (London, England). 7: 45. PMID 20804552 DOI: 10.1186/1476-9255-7-45 |
0.01 |
|
| 2009 |
Yu PJ, Skolnick A, Ferrari G, Heretis K, Mignatti P, Pintucci G, Rosenzweig B, Diaz-Cartelle J, Kronzon I, Perk G, Pass HI, Galloway AC, Grossi EA, Grau JB. Correlation between plasma osteopontin levels and aortic valve calcification: potential insights into the pathogenesis of aortic valve calcification and stenosis. The Journal of Thoracic and Cardiovascular Surgery. 138: 196-9. PMID 19577079 DOI: 10.1016/j.jtcvs.2008.10.045 |
0.01 |
|
| 2009 |
Kallenbach K, Salcher R, Heim A, Karck M, Mignatti P, Haverich A. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3. Journal of Vascular Surgery. 49: 750-8. PMID 19268777 DOI: 10.1016/j.jvs.2008.11.001 |
0.01 |
|
| 2009 |
Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. Journal of Cellular Physiology. 219: 449-58. PMID 19180561 DOI: 10.1002/jcp.21706 |
0.01 |
|
| 2009 |
Gulkarov I, Bohmann K, Cinnante KM, Pirelli L, Yu PJ, Grau JB, Pintucci G, Galloway AC, Mignatti P. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts. The Journal of Surgical Research. 154: 150-6. PMID 18805551 DOI: 10.1016/j.jss.2008.04.025 |
0.01 |
|
| 2008 |
Cook BD, Ferrari G, Pintucci G, Mignatti P. TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling. Journal of Cellular Biochemistry. 105: 1367-73. PMID 18980215 DOI: 10.1002/jcb.21935 |
0.01 |
|
| 2008 |
D'Alessio S, Ferrari G, Cinnante K, Scheerer W, Galloway AC, Roses DF, Rozanov DV, Remacle AG, Oh ES, Shiryaev SA, Strongin AY, Pintucci G, Mignatti P. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. The Journal of Biological Chemistry. 283: 87-99. PMID 17991754 DOI: 10.1074/jbc.M705492200 |
0.01 |
|
| 2008 |
Yu PJ, Ferrari G, Pirelli L, Galloway AC, Mignatti P, Pintucci G. Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity. Oncogene. 27: 2594-601. PMID 17968311 DOI: 10.1038/sj.onc.1210899 |
0.01 |
|
| 2007 |
Yu PJ, Ferrari G, Pirelli L, Gulkarov I, Galloway AC, Mignatti P, Pintucci G. Vascular injury and modulation of MAPKs: a targeted approach to therapy of restenosis. Cellular Signalling. 19: 1359-71. PMID 17448633 DOI: 10.1016/j.cellsig.2007.03.002 |
0.01 |
|
| 2007 |
Yu PJ, Ferrari G, Galloway AC, Mignatti P, Pintucci G. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. Journal of Cellular Biochemistry. 100: 1100-8. PMID 17131363 DOI: 10.1002/jcb.21116 |
0.01 |
|
| 2006 |
Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC, Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 103: 17260-5. PMID 17088559 DOI: 10.1073/pnas.0605556103 |
0.01 |
|
| 2006 |
Gulkarov I, Pintucci G, Bohmann K, Saunders PC, Sullivan RF, Ferrari G, Mignatti P, Galloway AC. Mechanisms of c-reactive protein up-regulation in arterialized vein grafts. Surgery. 139: 254-62. PMID 16455335 DOI: 10.1016/J.Surg.2005.08.002 |
0.01 |
|
| 2006 |
Pintucci G, Saunders PC, Gulkarov I, Sharony R, Kadian-Dodov DL, Bohmann K, Baumann FG, Galloway AC, Mignatti P. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 398-400. PMID 16303874 DOI: 10.1096/fj.05-4114fje |
0.01 |
|
| 2006 |
Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC, Mignatti P. Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. American Journal of Physiology. Heart and Circulatory Physiology. 290: H1651-9. PMID 16284240 DOI: 10.1152/ajpheart.00530.2005 |
0.01 |
|
| 2006 |
Pirelli L, Yu PJ, Gulkarov I, Galloway AC, Mignatti P, Pintucci G. Inhibition of mitogen-activated protein kinases (MAPKs) as a strategy to prevent intimal hyperplasia following cardiovascular interventions Vascular Disease Prevention. 3: 173-183. DOI: 10.2174/156727006778019121 |
0.01 |
|
| 2005 |
Pintucci G, Yu PJ, Saponara F, Kadian-Dodov DL, Galloway AC, Mignatti P. PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus. Journal of Cellular Biochemistry. 95: 1292-300. PMID 15962299 DOI: 10.1002/jcb.20505 |
0.01 |
|
| 2005 |
Del Rosso M, Fibbi G, Schmitt M, Mignatti P. Proteases and extracellular environment. Thrombosis and Haemostasis. 93: 190-1. PMID 15711731 DOI: 10.1267/THRO05020190 |
0.01 |
|
| 2004 |
Saunders PC, Pintucci G, Bizekis CS, Sharony R, Hyman KM, Saponara F, Baumann FG, Grossi EA, Colvin SB, Mignatti P, Galloway AC. Vein graft arterialization causes differential activation of mitogen-activated protein kinases. The Journal of Thoracic and Cardiovascular Surgery. 127: 1276-84. PMID 15115983 DOI: 10.1016/j.jtcvs.2003.07.017 |
0.01 |
|
| 2003 |
Pintucci G, Yu PJ, Sharony R, Baumann FG, Saponara F, Frasca A, Galloway AC, Moscatelli D, Mignatti P. Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2-/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). Journal of Cellular Biochemistry. 90: 1015-25. PMID 14624461 DOI: 10.1002/jcb.10721 |
0.01 |
|
| 2003 |
Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G, Saladino F, Dolo V, Dell'Era P, Pavan A, Pizzolanti G, Mignatti P, Presta M, Vittorelli ML. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. The Journal of Biological Chemistry. 278: 51911-9. PMID 14523006 DOI: 10.1074/jbc.M304192200 |
0.01 |
|
| 2003 |
Bizekis C, Pintucci G, Derivaux CC, Saponara F, Kim JH, Hyman KM, Sharony R, Grossi EA, Baumann FG, Mignatti P, Galloway AC. Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor. The Journal of Thoracic and Cardiovascular Surgery. 126: 659-65. PMID 14502136 DOI: 10.1016/S0022-5223(03)00075-8 |
0.01 |
|
| 2003 |
Kallenbach K, Fernandez HA, Seghezzi G, Baumann FG, Patel S, Grossi EA, Galloway AC, Mignatti P. A quantitative in vitro model of smooth muscle cell migration through the arterial wall using the human amniotic membrane. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1008-13. PMID 12676801 DOI: 10.1161/01.ATV.0000069880.81136.38 |
0.01 |
|
| 2002 |
Pintucci G, Froum S, Pinnell J, Mignatti P, Rafii S, Green D. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thrombosis and Haemostasis. 88: 834-42. PMID 12428103 DOI: 10.1267/th02110834 |
0.01 |
|
| 2002 |
Hyman KM, Seghezzi G, Pintucci G, Stellari G, Kim JH, Grossi EA, Galloway AC, Mignatti P. Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery. 132: 173-9. PMID 12219008 DOI: 10.1067/msy.2002.125304 |
0.01 |
|
| 2002 |
Monea S, Lehti K, Keski-Oja J, Mignatti P. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. Journal of Cellular Physiology. 192: 160-70. PMID 12115722 DOI: 10.1002/Jcp.10126 |
0.01 |
|
| 2002 |
Malhotra S, Newman E, Eisenberg D, Scholes J, Wieczorek R, Mignatti P, Shamamian P. Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: a possible mechanism of neoplastic progression. Diseases of the Colon and Rectum. 45: 537-43. PMID 12006939 DOI: 10.1007/s10350-004-6236-7 |
0.01 |
|
| 2002 |
Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti P. Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 598-600. PMID 11919166 DOI: 10.1096/Fj.01-0815Fje |
0.01 |
|
| 2001 |
Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, Mignatti P. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. Journal of Cellular Physiology. 189: 197-206. PMID 11598905 DOI: 10.1002/Jcp.10014 |
0.01 |
|
| 2000 |
Liao F, Li Y, O'Connor W, Zanetta L, Bassi R, Santiago A, Overholser J, Hooper A, Mignatti P, Dejana E, Hicklin DJ, Bohlen P. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Research. 60: 6805-10. PMID 11156369 |
0.01 |
|
| 2000 |
Shamamian P, Pocock BJ, Schwartz JD, Monea S, Chuang N, Whiting D, Marcus SG, Galloway AC, Mignatti P. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion. Surgery. 127: 142-7. PMID 10686978 DOI: 10.1067/Msy.2000.101155 |
0.01 |
|
| 2000 |
Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, Shamamian P, Mignatti P. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. International Journal of Cancer. Journal International Du Cancer. 85: 281-8. PMID 10629090 DOI: 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3 |
0.01 |
|
| 2000 |
Mignatti P, Rifkin DB. Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Advances in Cancer Research. 78: 103-57. PMID 10547669 |
0.01 |
|
| 1999 |
Pintucci G, Steinberg BM, Seghezzi G, Yun J, Apazidis A, Baumann FG, Grossi EA, Colvin SB, Mignatti P, Galloway AC. Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases. Surgery. 126: 422-7. PMID 10455916 DOI: 10.1016/S0039-6060(99)70187-X |
0.01 |
|
| 1999 |
Monea S, Roberts B, Marcus SG, Shamamian P, Mignatti P. Roles of MT1-MMP in the regulation of cell surface proteolysis. Annals of the New York Academy of Sciences. 878: 703-6. PMID 10415813 DOI: 10.1111/J.1749-6632.1999.Tb07767.X |
0.01 |
|
| 1999 |
Fernandez HA, Kallenbach K, Seghezzi G, Grossi E, Colvin S, Schneider R, Mignatti P, Galloway A. Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1. The Journal of Surgical Research. 82: 156-62. PMID 10090824 DOI: 10.1006/Jsre.1998.5534 |
0.01 |
|
| 1998 |
Ren CJ, Ueda F, Roses DF, Harris MN, Mignatti P, Rifkin DB, Shapiro RL. Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice. The Journal of Surgical Research. 77: 126-31. PMID 9733598 DOI: 10.1006/jsre.1998.5381 |
0.01 |
|
| 1998 |
Schwartz JD, Shamamian P, Monea S, Whiting D, Marcus SG, Galloway AC, Mignatti P. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Surgery. 124: 232-8. PMID 9706143 DOI: 10.1016/S0039-6060(98)70125-4 |
0.01 |
|
| 1998 |
Fernandez HA, Kallenbach K, Seghezzi G, Mehrara B, Apazidis A, Baumann FG, Grossi EA, Colvin S, Mignatti P, Galloway AC. Modulation of matrix metalloproteinase activity in human saphenous vein grafts using adenovirus-mediated gene transfer. Surgery. 124: 129-36. PMID 9706130 DOI: 10.1016/S0039-6060(98)70112-6 |
0.01 |
|
| 1998 |
Schwartz JD, Monea S, Marcus SG, Patel S, Eng K, Galloway AC, Mignatti P, Shamamian P. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. The Journal of Surgical Research. 76: 79-85. PMID 9695744 DOI: 10.1006/Jsre.1998.5294 |
0.01 |
|
| 1998 |
Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. The Journal of Cell Biology. 141: 1659-73. PMID 9647657 DOI: 10.1083/jcb.141.7.1659 |
0.01 |
|
| 1997 |
Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. The Journal of Biological Chemistry. 272: 17216-22. PMID 9202045 DOI: 10.1074/jbc.272.27.17216 |
0.01 |
|
| 1997 |
Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. The Embo Journal. 16: 2319-32. PMID 9171346 DOI: 10.1093/Emboj/16.9.2319 |
0.01 |
|
| 1996 |
Seghezzi G, Marelli R, Mandriota SJ, Nolli ML, Mazzieri R, Mignatti P. Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells. Journal of Cellular Physiology. 169: 300-8. PMID 8908197 DOI: 10.1002/(SICI)1097-4652(199611)169:2<300::AID-JCP9>3.0.CO;2-S |
0.01 |
|
| 1996 |
Mignatti P, Rifkin DB. Plasminogen activators and angiogenesis. Current Topics in Microbiology and Immunology. 213: 33-50. PMID 8814993 |
0.01 |
|
| 1996 |
Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme & Protein. 49: 117-37. PMID 8797002 |
0.01 |
|
| 1995 |
Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. The Journal of Biological Chemistry. 270: 9709-16. PMID 7730348 DOI: 10.1074/jbc.270.17.9709 |
0.01 |
|
| 1995 |
Bikfalvi A, Klein S, Pintucci G, Quarto N, Mignatti P, Rifkin DB. Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. The Journal of Cell Biology. 129: 233-43. PMID 7698988 DOI: 10.1083/jcb.129.1.233 |
0.01 |
|
| 1995 |
Mignatti P. Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney International. Supplement. 49: S12-4. PMID 7674585 |
0.01 |
|
| 1995 |
Mignatti P, Ziche M. Funding Italian research [8] Science. 269: 1499-1500. |
0.01 |
|
| 1994 |
Peverali FA, Mandriota SJ, Ciana P, Marelli R, Quax P, Rifkin DB, Della Valle G, Mignatti P. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. Journal of Cellular Physiology. 161: 1-14. PMID 7523424 DOI: 10.1002/jcp.1041610102 |
0.01 |
|
| 1994 |
Mazzieri R, Høyer-Hansen G, Rønne E, Løber D, Vagnarelli P, Raimondi E, De Carli L, Danø K, Mignatti P. Urokinase and urokinase receptor expression in somatic cell hybrids Fibrinolysis and Proteolysis. 8: 344-352. DOI: 10.1016/0268-9499(94)90002-7 |
0.01 |
|
| 1993 |
Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiological Reviews. 73: 161-95. PMID 8419965 |
0.01 |
|
| 1993 |
Blei F, Wilson EL, Mignatti P, Rifkin DB. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. Journal of Cellular Physiology. 155: 568-78. PMID 7684043 DOI: 10.1002/jcp.1041550315 |
0.01 |
|
| 1993 |
Mignatti P. The fibrinolytic system and angiogenesis Fibrinolysis and Proteolysis. 7: 20-21. DOI: 10.1016/0268-9499(93)90085-A |
0.01 |
|
| 1992 |
Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. Journal of Cellular Physiology. 151: 81-93. PMID 1560052 DOI: 10.1002/jcp.1041510113 |
0.01 |
|
| 1992 |
Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. The Journal of Cell Biology. 118: 901-9. PMID 1380001 DOI: 10.1083/Jcb.118.4.901 |
0.01 |
|
| 1992 |
Vagnarelli P, Raimondi E, Mazzieri R, De Carli L, Mignatti P. Assignment of the human urokinase receptor gene (PLAUR) to 19q13. Cytogenetics and Cell Genetics. 60: 197-9. PMID 1324136 |
0.01 |
|
| 1991 |
Rifkin DB, Quarto N, Mignatti P, Bizik J, Moscatelli D. New observations on the intracellular localization and release of bFGF. Annals of the New York Academy of Sciences. 638: 204-6. PMID 1785802 |
0.01 |
|
| 1991 |
Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proceedings of the National Academy of Sciences of the United States of America. 88: 11007-11. PMID 1763016 |
0.01 |
|
| 1991 |
Mignatti P, Rifkin DB. Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? Journal of Cellular Biochemistry. 47: 201-7. PMID 1724242 DOI: 10.1002/jcb.240470303 |
0.01 |
|
| 1991 |
Mignatti P, Mazzieri R, Rifkin DB. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. The Journal of Cell Biology. 113: 1193-201. PMID 1645739 |
0.01 |
|
| 1990 |
Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P. Growth factor control of extracellular proteolysis. Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists. 32: 313-8. PMID 1711916 DOI: 10.1016/0922-3371(90)90045-X |
0.01 |
|
| 1989 |
Rifkin DB, Tsuboi R, Mignatti P. The role of proteases in matrix breakdown during cellular invasion. The American Review of Respiratory Disease. 140: 1112-3. PMID 2679264 DOI: 10.1164/ajrccm/140.4.1112 |
0.01 |
|
| 1989 |
Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. The Journal of Cell Biology. 108: 671-82. PMID 2465298 |
0.01 |
|
| 1989 |
De Petro G, Miggiano V, Mignatti P, Vartio T, Vaheri A, Barlati S. Neutralization of transformation-enhancing activity by anti-fibronectin monoclonal antibodies Cancer Journal. 2: 231-235. |
0.01 |
|
| 1988 |
Barlati S, De Petro G, Colombi M, Rebessi L, Adamoli A, Brega A, Mignatti P. Transformation enhancing factors in vitro and in vivo. Potential as cancer markers Cancer Journal. 2: 95-104. |
0.01 |
|
| 1987 |
Barlati S, Colombi M, Mignatti P. Plasminogen activator activity of human plasma and transformed cells conditioned media: Dependence on divalent cations Fibrinolysis and Proteolysis. 1: 189-194. DOI: 10.1016/0268-9499(87)90009-9 |
0.01 |
|
| 1986 |
Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell. 47: 487-98. PMID 3022933 DOI: 10.1016/0092-8674(86)90613-6 |
0.01 |
|
| 1986 |
Moscatelli DA, Presta M, Mignatti P, Mullins DE, Crowe RM, Rifkin DB. Purification and biological activities of an angiogenesis factor from human placenta. Anticancer Research. 6: 861-3. PMID 3019226 |
0.01 |
|
| 1985 |
Mignatti P, Pagani L, Perduca M, Romero E. R factor-mediated adhesiveness to mammalian cells in E. coli K12. Microbiologica. 8: 101-11. PMID 3892231 |
0.01 |
|
| 1985 |
Mignatti P, Speziale P, Pagani L, Romero E. Degradation of human fibronectin by strains of E. coli K12 carrying R factors from Klebsiella pneumoniae. Microbiologica. 8: 67-71. PMID 3883102 |
0.01 |
|
| 1985 |
Presta M, Mignatti P, Mullins DE, Moscatelli DA. Human placental tissue stimulates bovine capillary endothelial cell growth, migration and protease production. Bioscience Reports. 5: 783-90. PMID 2417639 DOI: 10.1007/BF01119877 |
0.01 |
|
| 1985 |
Mignatti P, Speziale P, Debiaggi M. Biochemical characterization of coronavirus inhibiting activity present in human and bovine sera | CARATTERIZZAZIONE BIOCHIMICA DELL'INIBITORE SIERICO NON ANTICORPALE DEI CORONAVIRUS Igiene Moderna. 83: 203-208. |
0.01 |
|
| 1984 |
Romero E, Pagani L, Perduca M, Mignatti P, Malfa S, Mills V. Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae. Microbiologica. 7: 209-18. PMID 6334220 |
0.01 |
|
| 1984 |
Saksela O, Vaheri A, Schleuning WD, Mignatti P, Barlati S. Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells. International Journal of Cancer. Journal International Du Cancer. 33: 609-16. PMID 6202645 |
0.01 |
|
| 1984 |
Cereda PM, Debiaggi M, Mignatti P, Pagani L, Romero E. Bovine leukemia virus inhibiting activity in fetal calf serum. Microbiologica. 7: 251-6. PMID 6094986 |
0.01 |
|
| 1983 |
Mignatti P, Pagani L, Romero E. A plasmid-linked caseinolytic activity in Enterobacteriaceae. Microbiologica. 6: 229-37. PMID 6355775 |
0.01 |
|
| 1983 |
Mignatti P. A method for evaluating the statistical accuracy of in vitro virus titrations. Microbiologica. 6: 55-68. PMID 6341780 |
0.01 |
|
| 1982 |
Mignatti P, Barlati S. Enhancement of plasminogen activator activity by the culture medium of Rous sarcoma virus-transformed cells. The Journal of General Virology. 63: 365-73. PMID 6296283 |
0.01 |
|
| 1981 |
Kryceve-Martinerie C, Biquard JM, Lawrence D, Vigier P, Barlati S, Mignatti P. Transformation-enhancing factor(s) released from chicken Rous sarcoma cells: effect on some transformation parameters. Virology. 112: 436-49. PMID 6266136 DOI: 10.1016/0042-6822(81)90291-9 |
0.01 |
|
| 1980 |
Mignatti P, Ascari E, Barlati S. Potential diagnostic and prognostic significance of the transformation-enhancing factor(s) in the plasma cryoprecipitate of tumor patients. International Journal of Cancer. Journal International Du Cancer. 25: 727-34. PMID 14768701 |
0.01 |
|
| 1980 |
Calothy G, Poirier F, Dambrine G, Mignatti P, Combes P, Pessac B. Expression of viral oncogenes in differentiating chick embryo neuroretinal cells infected with avian tumor viruses. Cold Spring Harbor Symposia On Quantitative Biology. 44: 983-90. PMID 6253230 |
0.01 |
|
| 1980 |
de Petro G, Brega A, Mignatti P, Barlati S. Inhibition of Rous sarcoma-virus-induced transformation by proteins involved in blood coagulation. International Journal of Cancer. Journal International Du Cancer. 25: 557-60. PMID 6102967 |
0.01 |
|
| 1975 |
Barlati S, Mignatti P, Kryceve C, Vigier P. Properties and kinetics of development of Rous sarcoma virus-infected cells evidenced by methylene blue staining. Intervirology. 6: 25-31. PMID 57944 |
0.01 |
|
| Hide low-probability matches. |